EPISODE · Apr 10, 2025 · 57 MIN
First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor
from Lung Cancer Update
Dr Justin F Gainor from Massachusetts General Hospital in Boston reviews available clinical data on ALK inhibitors and first-line treatment strategies for ALK-positive metastatic non-small cell lung cancer. CME information and select publications here.
Embed this episode
Ready to play
First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor
0:00
57:28
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of Lung Cancer Update?
This episode is 57 minutes long.
When was this Lung Cancer Update episode published?
This episode was published on April 10, 2025.
Can I download this Lung Cancer Update episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!